Humanin gene expression in fibroblast of Down syndrome subjects.
Salemi. Michele M; Ridolfo. Federico F; Salluzzo. Maria Grazia MG; Cannarrella. Rossella R; Giambirtone. Mariaconcetta M; Caniglia. Salvatore S; Tirolo. Cataldo C; Ferri. Raffaele R; Romano. Corrado C
Key Findings
- Humanin protein and mRNA levels are significantly higher in fibroblasts from Down syndrome patients compared to controls
- The increase was confirmed using immunocytochemistry, western blot, and qRT‑PCR techniques
- The authors propose that elevated humanin could contribute to the Down syndrome phenotype
Practical Outcomes
- The finding is interesting for those tracking mitochondrial peptides, but it doesn’t translate into a concrete supplement or protocol yet. It signals that humanin may be involved in cellular stress responses, so future work could explore whether boosting humanin has benefits for brain or metabolic health, but more evidence is needed before trying it.
Summary
Researchers found that cells taken from people with Down syndrome make more of a tiny protein called humanin, which is known to protect cells from stress. This suggests humanin might be part of why Down syndrome cells behave differently, but the study doesn’t test any treatments or give dosing advice.
Abstract
Down syndrome (DS) is characterized by trisomy of chromosome 21 and peculiar phenotype. Humanin (HN) is a mitochondrial short 24-residue polypeptide whit anti-apoptotic and neuroprotective effects. In this study we evaluated HN protein expression and HN mRNA levels in cultured fibroblasts from DS patients and normal controls. Our results obtained by immunocytochemistry, western-blot and qRT-PCR analysis show a significant HN up-regulation in DS patients. These results confirm previous studies and suggest a role for HN may in the DS phenotype.
Study Information
pubmed
2020
2020-01-18T00:00:00.000Z
10.7150/ijms.39145
11
15